Q3 2024 Holdings
Filed 2024-11-13 | 86 holdings | $732.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $45.0M | 1,144,021 | 6.1% |
| Cassava Sciences Inc(SAVA)Put | COM | 14817C107 | $42.7M | 1,449,300 | 5.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $39.0M | 664,198 | 5.3% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $34.5M | 337,500 | 4.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $33.4M | 400,000 | 4.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $28.0M | 1,000,000 | 3.8% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $25.2M | 1,400,000 | 3.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $21.2M | 100,000 | 2.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $20.4M | 400,000 | 2.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $19.3M | 860,399 | 2.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $19.2M | 435,000 | 2.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $18.7M | 650,000 | 2.6% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $18.0M | 1,000,000 | 2.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $16.3M | 4,500,000 | 2.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $15.4M | 965,612 | 2.1% |
| Inozyme Pharma Inc | COM | 45790W108 | $14.8M | 2,822,318 | 2.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $14.7M | 498,420 | 2.0% |
| Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | $14.6M | $21,525,000 | 2.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.4M | 687,785 | 1.8% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $13.1M | $16,625,000 | 1.8% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $12.6M | 290,447 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.9M | 525,000 | 1.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $11.5M | 1,400,000 | 1.6% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $9.6M | $12,250,000 | 1.3% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $8.6M | 349,836 | 1.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.2M | 1,700,000 | 1.1% |
| Merus N V | COM | N5749R100 | $8.1M | 161,741 | 1.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $8.0M | 725,106 | 1.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $7.9M | 35,000 | 1.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $7.8M | 472,390 | 1.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.6M | 300,000 | 1.0% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $7.6M | 1,500,000 | 1.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.2M | 80,000 | 1.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $6.8M | 2,499,431 | 0.9% |
| Geron Corp(GERN) | COM | 374163103 | $6.8M | 1,500,000 | 0.9% |
| Anaptysbio Inc(ANAB)Put | COM | 032724106 | $6.7M | 200,000 | 0.9% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $6.7M | 500,000 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $6.4M | 225,000 | 0.9% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $6.3M | 325,000 | 0.9% |
| ARS Pharmaceuticals Inc(SPRY)Call | COM | 82835W108 | $5.8M | 400,000 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.7M | 50,000 | 0.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $5.5M | 225,000 | 0.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $5.0M | 600,000 | 0.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $4.7M | 147,500 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $4.4M | 263,817 | 0.6% |
| Travere Therapeutics Inc | NOTE 2.250% 3/0 | 89422GAA5 | $4.3M | $5,000,000 | 0.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.2M | 125,000 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.2M | 350,000 | 0.6% |
| Novavax Inc(NVAX)Call | COM NEW | 670002401 | $3.8M | 300,000 | 0.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.7M | 50,000 | 0.5% |